A five-story, 346-unit apartment building marks the first phase of the planned mixed-use redevelopment of the former Shadowdale grain elevators.

The expansion, announced Feb. 24, builds on an earlier 250-bed phase and brings the customized campus to support up to 1,050 ...

After cutting down its pipeline just a few months ago, OSE Immunotherapeutics is at it again, this time reorganizing as Boehringer Ingelheim walks away from the biotech’s metabolic ...

Here's what experts recommend student loan borrowers do after a recent victory in court for the Biden administration-era SAVE plan.

Funding to advance Demonstration Facility construction and operations along with critical engineering for the completion of the Clearwater Project ...

VANCOUVER, BC / ACCESS Newswire / March 2, 2026 / Revolve Renewable Power Corp. (CSE:REVV)(OTCQB:REVVF) ("Revolve" or ...

A major mixed-use development is moving ahead in Stonewall, bringing new commercial space, housing options and a brand-new ...

NUBURU, Inc. (NYSE American: BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, and software-orchestrated defense systems, today ...

Q4 revenue -- $67.3 million reported for the quarter ended Dec. 31, 2025, compared to $1.5 million in Q4 2024; increase driven primarily by AstraZeneca and Gilead (NASDAQ:GILD) payments. Full-year ...

Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Held Type A meeting with FDA to discuss AMT-130 for Huntington’s disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of ...